AusBiotech has launched its annual consultation of membership issues, calling for leaders of biotechnology companies to respond to the annual CEO Biotechnology Industry Position Survey 2017, as a matter of importance.
AusBiotech conducts the confidential survey and holds supporting roundtables in each state early each year, to seek formally, opinions and information from the leaders of the industry it represents, to get a comprehensive view of the Australian biotechnology sector based on industry experience, knowledge, key metrics and political insight.
The survey takes the annual snapshot of the industry to build the advocacy platform for the year to come – and will have added significance this year, given the recent review of the R&D Tax Incentive, new Ministers in Health and Industry, Innovation and Science and the Government’s plans for innovation through its National Innovation and Science Agenda.
The survey and the focus groups help build metrics about the significance of the industry and its perspectives and help us to make strong statements about the magnitude of issues and trends. The collated results appear in a widely-used printed report that informs and gives valuable ballast to AusBiotech’s advocacy efforts.
AusBiotech will hold the roundtables in March and April and the hard-copy report will be launched prior to the 2017 Federal Budget.
The Survey is once again proudly supported by Grant Thornton, as part of its commitment to work constructively with the Australian biotechnology industry through its activities and support.
For further information, to signal interest in the roundtables, or to check if your company has participated, please contact Deputy CEO, Lorraine Chiroiu (firstname.lastname@example.org or 03 9828 1400).